Is Pharma Force Liège still active?

Yes, Pharma Force Liège is currently active.

What does Pharma Force Liège do?

Pharma Force Liège's registered main activity is Retail sale of pharmaceutical products. It is also registered for 9 additional activities.

Where is Pharma Force Liège registered?

Pharma Force Liège's registered address is Poortakkerstraat 41G, 9051 Gent, Belgium.

How many employees does Pharma Force Liège have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2024), Pharma Force Liège reported 105.4 full-time equivalent employees.

What is Pharma Force Liège's annual turnover?

Pharma Force Liège's most recently filed annual turnover (fiscal year ending 31 Dec 2024) was €23,129,723.

Did Pharma Force Liège make a profit or a loss?

Pharma Force Liège's most recently filed annual accounts (fiscal year ending 31 Dec 2024) reported a profit of €1,929,557.

When did Pharma Force Liège last file annual accounts?

Pharma Force Liège's most recently filed annual accounts cover the fiscal year ending 31 Dec 2024.

Is Pharma Force Liège B Corp certified?

We have no B Corp certification on file for Pharma Force Liège.

Does Pharma Force Liège hold Fairtrade certification?

No, Pharma Force Liège does not currently hold Fairtrade certification.

Pharma Force Liège

Q: When was Pharma Force Liège founded?

Pharma Force Liège was founded on 08 Jul 2003, making it 23 years old.

BE 0859.585.888

Copied!

NV/SA

Status

Active

Founded

08 Jul 2003 · 23 yrs

Size

Medium · 105.4 FTE

Legal name

Pharma Force

Main activity

Retail sale of pharmaceutical products

Website

pharmaforce.be

Activities

10 activities

Retail sale of pharmaceutical productsManufacture of medicamentsRetail sale of cosmetic and toilet articlesManufacture of veterinary preparationsStudy, development of the production of active ingredients for drug manufacturingManufacture of diverse medicaments, including homeopathic preparationsManufacture of chemical contraceptive products for external use and hormonal contraceptive medicamentsManufacture of other organic basic chemicalsRetail sale of other food n.e.c.Retail sale of medical and orthopaedic goods, except corrective glasses, lenses and sunglasses

Financials

Turnover2024

€23.1M-5.2%

Profit / Loss2024

€1.9M-12.9%

Equity2024

€11.2M+20.7%

2024	2023	2022	2021
€23,129,723-5.2%	€24,406,503+2.4%	€23,826,577-7.1%	€25,645,528
€1,929,557-12.9%	€2,215,671-22%	€2,841,367-33.2%	€4,255,985
€11,240,770+20.7%	€9,311,213+31.2%	€7,095,542+66.8%	€4,254,175
€4,508,125-10.2%	€5,017,746-38.8%	€8,196,100-17.3%	€9,916,761
€140,909-2.1%	€143,867-46.1%	€266,698-23.6%	€349,072
105.4-0.7%	106.1-0.4%	106.5-5.8%	113
€219,447-4.6%	€230,033+2.8%	€223,724-1.4%	€226,952

Frequently asked questions

01What is Pharma Force Liège's official registered name?

Pharma Force.

02What is Pharma Force Liège's enterprise number (VAT number)?

BE 0859.585.888.

03What is Pharma Force Liège's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

04When was Pharma Force Liège founded?

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2024	2023	2022	2021
Income statement
	€23,129,723-5.2%	€24,406,503+2.4%	€23,826,577-7.1%	€25,645,528
	€4,858,938-0.4%	€4,878,185+0.1%	€4,875,935+2.7%	€4,748,143
	€2,061,010-17.7%	€2,505,294-18%	€3,054,932-33.1%	€4,564,904
	€1,929,557-12.9%	€2,215,671-22%	€2,841,367-33.2%	€4,255,985
	€223,925-49.4%	€442,668+58.2%	€279,909-33.7%	€422,504
Profitability
	8.3%-8.1%	9.1%-23.9%	11.9%-28.1%	16.6%
	17.2%-27.9%	23.8%-40.6%	40.0%-60%	100.0%
	12.3%-20.8%	15.5%-16.8%	18.6%-38.1%	30.0%
Solvency
	€15,748,895+9.9%	€14,328,959-6.3%	€15,291,642+7.9%	€14,170,936
	€1,224,287-13.1%	€1,408,611+9.6%	€1,284,813-19.4%	€1,594,274
	€140,408+10.2%	€127,373-4.9%	€133,903+19.8%	€111,738
	€11,240,770+20.7%	€9,311,213+31.2%	€7,095,542+66.8%	€4,254,175
	71.4%+9.8%	65.0%+40%	46.4%+54.6%	30.0%
	€253,803+30.1%	€195,065-50%	€390,554-43.1%	€686,534
	0.02+7.8%	0.02-61.9%	0.06-65.9%	0.16
	€4,508,125-10.2%	€5,017,746-38.8%	€8,196,100-17.3%	€9,916,761
	0.40-25.6%	0.54-53.3%	1.16-50.4%	2.33
	114.84-30.6%	165.53-3.2%	171.07-25.4%	229.26
Liquidity
	€140,909-2.1%	€143,867-46.1%	€266,698-23.6%	€349,072
	€1,289,202-12%	€1,464,651+9.5%	€1,337,361-9.2%	€1,473,025
	€6,964,937+8.6%	€6,412,257-43.6%	€11,379,165+16.7%	€9,747,614
	€2,084,956-24.9%	€2,776,058+10.7%	€2,508,682-18.1%	€3,063,788
	€4,253,646-11.8%	€4,822,663-38.2%	€7,805,152-15.4%	€9,230,227
	3.28+27.5%	2.57+48.6%	1.73+32.6%	1.31
	€9,843,906+27.3%	€7,733,859+29.3%	€5,983,104+88.1%	€3,180,085
Efficiency
	110 days+14.6%	96 days-45%	174 days+25.7%	139 days
	42 days-22.7%	55 days+5%	52 days-10%	58 days
	32 days-7.5%	35 days+6.6%	33 days+0.2%	33 days
	10.56-3.2%	10.91+3%	10.59	—
Profit appropriation
	€45,3460%	€45,3460%	€45,3460%	€45,346
	-€13,175,232+12.8%	-€15,104,789+12.8%	-€17,320,460+14.1%	-€20,161,827

Sources

NBB — Nationale Bank van België

	2024	2023	2022	2021
Income statement
	€23,129,723-5.2%	€24,406,503+2.4%	€23,826,577-7.1%	€25,645,528
	€4,858,938-0.4%	€4,878,185+0.1%	€4,875,935+2.7%	€4,748,143
	€2,061,010-17.7%	€2,505,294-18%	€3,054,932-33.1%	€4,564,904
	€1,929,557-12.9%	€2,215,671-22%	€2,841,367-33.2%	€4,255,985
	€223,925-49.4%	€442,668+58.2%	€279,909-33.7%	€422,504
Profitability
	8.3%-8.1%	9.1%-23.9%	11.9%-28.1%	16.6%
	17.2%-27.9%	23.8%-40.6%	40.0%-60%	100.0%
	12.3%-20.8%	15.5%-16.8%	18.6%-38.1%	30.0%
Solvency
	€15,748,895+9.9%	€14,328,959-6.3%	€15,291,642+7.9%	€14,170,936
	€1,224,287-13.1%	€1,408,611+9.6%	€1,284,813-19.4%	€1,594,274
	€140,408+10.2%	€127,373-4.9%	€133,903+19.8%	€111,738
	€11,240,770+20.7%	€9,311,213+31.2%	€7,095,542+66.8%	€4,254,175
	71.4%+9.8%	65.0%+40%	46.4%+54.6%	30.0%
	€253,803+30.1%	€195,065-50%	€390,554-43.1%	€686,534
	0.02+7.8%	0.02-61.9%	0.06-65.9%	0.16
	€4,508,125-10.2%	€5,017,746-38.8%	€8,196,100-17.3%	€9,916,761
	0.40-25.6%	0.54-53.3%	1.16-50.4%	2.33
	114.84-30.6%	165.53-3.2%	171.07-25.4%	229.26
Liquidity
	€140,909-2.1%	€143,867-46.1%	€266,698-23.6%	€349,072
	€1,289,202-12%	€1,464,651+9.5%	€1,337,361-9.2%	€1,473,025
	€6,964,937+8.6%	€6,412,257-43.6%	€11,379,165+16.7%	€9,747,614
	€2,084,956-24.9%	€2,776,058+10.7%	€2,508,682-18.1%	€3,063,788
	€4,253,646-11.8%	€4,822,663-38.2%	€7,805,152-15.4%	€9,230,227
	3.28+27.5%	2.57+48.6%	1.73+32.6%	1.31
	€9,843,906+27.3%	€7,733,859+29.3%	€5,983,104+88.1%	€3,180,085
Efficiency
	110 days+14.6%	96 days-45%	174 days+25.7%	139 days
	42 days-22.7%	55 days+5%	52 days-10%	58 days
	32 days-7.5%	35 days+6.6%	33 days+0.2%	33 days
	10.56-3.2%	10.91+3%	10.59	—
Profit appropriation
	€45,3460%	€45,3460%	€45,3460%	€45,346
	-€13,175,232+12.8%	-€15,104,789+12.8%	-€17,320,460+14.1%	-€20,161,827

2024

2023

2022

2021

Income statement

€23,129,723-5.2%

€24,406,503+2.4%

€23,826,577-7.1%

€25,645,528

€4,858,938-0.4%

€4,878,185+0.1%

€4,875,935+2.7%

€4,748,143

€2,061,010-17.7%

€2,505,294-18%

€3,054,932-33.1%

€4,564,904

€1,929,557-12.9%

€2,215,671-22%

€2,841,367-33.2%

€4,255,985

€223,925-49.4%

€442,668+58.2%

€279,909-33.7%

€422,504

Profitability

8.3%-8.1%

9.1%-23.9%

11.9%-28.1%

16.6%

17.2%-27.9%

23.8%-40.6%

40.0%-60%

100.0%

12.3%-20.8%

15.5%-16.8%

18.6%-38.1%

30.0%

Solvency

€15,748,895+9.9%

€14,328,959-6.3%

€15,291,642+7.9%

€14,170,936

€1,224,287-13.1%

€1,408,611+9.6%

€1,284,813-19.4%

€1,594,274

€140,408+10.2%

€127,373-4.9%

€133,903+19.8%

€111,738

€11,240,770+20.7%

€9,311,213+31.2%

€7,095,542+66.8%

€4,254,175

71.4%+9.8%

65.0%+40%

46.4%+54.6%

30.0%

€253,803+30.1%

€195,065-50%

€390,554-43.1%

€686,534

0.02+7.8%

0.02-61.9%

0.06-65.9%

0.16

€4,508,125-10.2%

€5,017,746-38.8%

€8,196,100-17.3%

€9,916,761

0.40-25.6%

0.54-53.3%

1.16-50.4%

2.33

114.84-30.6%

165.53-3.2%

171.07-25.4%

229.26

Liquidity

€140,909-2.1%

€143,867-46.1%

€266,698-23.6%

€349,072

€1,289,202-12%

€1,464,651+9.5%

€1,337,361-9.2%

€1,473,025

€6,964,937+8.6%

€6,412,257-43.6%

€11,379,165+16.7%

€9,747,614

€2,084,956-24.9%

€2,776,058+10.7%

€2,508,682-18.1%

€3,063,788

€4,253,646-11.8%

€4,822,663-38.2%

€7,805,152-15.4%

€9,230,227

3.28+27.5%

2.57+48.6%

1.73+32.6%

1.31

€9,843,906+27.3%

€7,733,859+29.3%

€5,983,104+88.1%

€3,180,085

Efficiency

110 days+14.6%

96 days-45%

174 days+25.7%

139 days

42 days-22.7%

55 days+5%

52 days-10%

58 days

32 days-7.5%

35 days+6.6%

33 days+0.2%

33 days

10.56-3.2%

10.91+3%

10.59

—

Profit appropriation

€45,3460%

€45,346

-€13,175,232+12.8%

-€15,104,789+12.8%

-€17,320,460+14.1%

-€20,161,827

Pharma Force Liège

Activities

Financials

Frequently asked questions

All locations

All locations